Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Double-stranded RNA-activated protein kinase (PKR) is a serine/threonine protein kinase that plays a central role in the cellular response to viral infection and various stress signals. It is primarily known for its role in the innate immune response against viruses, becoming activated upon binding to double-stranded RNA (dsRNA). Once activated, PKR phosphorylates the eukaryotic translation initiation factor 2 alpha (eIF2α), leading to inhibition of global mRNA translation. Beyond antiviral defense, PKR also responds to other stressors and has regulatory functions balancing cell survival/apoptosis/inflammation.
Inhibition of eIF2α phosphorylation, inhibition of PKR dimerization and autophosphorylation, induction of apoptosis, modulation of inflammatory signaling pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Double-stranded RNA-activated protein kinase (PKR).